Assessment of nodal target definition and dosimetry using three different techniques: Implications for re-defining the optimal pelvic field in endometrial cancer

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Guo, Susan ^a,b   Ennis, Ronald D ^a,c   Bhatia, Stephen ^a   Trichter, Frieda ^a   Bashist, Benjamin ^a   Shah, Jinesh ^b   Chadha, Manjeet ^a,c  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL HYSTERECTOMY; ARTICLE; BLADDER; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSE VOLUME HISTOGRAM; DOSIMETRY; ENDOMETRIUM CANCER; HUMAN; POSTOPERATIVE CARE; PRACTICE GUIDELINE; RADIATION DOSE; RADIOTHERAPY; RECTUM; SALPINGOOOPHORECTOMY; SMALL INTESTINE; TREATMENT PLANNING; COMPUTER ASSISTED RADIOTHERAPY; ENDOMETRIUM TUMOR; FEMALE; LYMPH NODE; METHODOLOGY; RADIATION EXPOSURE; RADIOMETRY;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL;

EID: 77953858462     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-59     Document Type: Article

References (16)

1. Bonin SR, Lanciano RM, Corn BW, et al. Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy. Int J Radiat Oncol Biol Phys 1996, 34:167-172.
2. Greer BE, Koh WJ, Figge DC, et al. Gynecologic radiotherapy fields defined by intraoperative measurements. Gynecol Oncol 1990, 38:421-424. 10.1016/0090-8258(90)90084-X, 2227555.
3. McAlpine A, Schlaerth J, Lim P, et al. Radiation fields in gynecologic oncology: Correlation of soft tissue (surgical) to radiologic landmarks. Gynecol Oncol 2004, 92:25-30. 10.1016/j.ygyno.2003.09.008, 14751134.
4. Pendlebury SC, Cahill S, Crandon AJ, et al. Role of bipedal lymphangiogram in radiation treatment planning for cervix cancer. Int J Radiat Oncol Biol Phys 1993, 27:959-962.
5. Finlay MH, Ackerman I, Tirona RG, et al. Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks. Int J Radiat Oncol Biol Phys 2006, 64:205-209.
6. Portaluri M, Bambace S, Perez C, et al. A three-dimensional definition of nodal spaces on the basis of CT images showing enlarged nodes for pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63:1101-1107.
7. Taylor A, Rockall A, Reznek RH, et al. Mapping pelvic lymph nodes: Guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63:1604-1612. 10.1016/j.ijrobp.2005.05.062, 16198509.
8. Shih HA, Harisinghani M, Zietman AL, et al. Mapping of nodal disease in locally advanced prostate cancer: Rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. Int J Radiat Oncol Biol Phys 2005, 63:1262-1269.
9. Vilarino-Varela MJ, Taylor A, Rockall AG, et al. A verification study of proposed pelvic lymph node localisation guidelines using nanoparticle-enhanced magnetic resonance imaging. Radiother Oncol 2008, 89:192-196. 10.1016/j.radonc.2008.07.023, 18771811.
10. Dinniwell R, Chan P, Czarnota G, et al. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2009, 74:844-851.
11. Jhingran A, Winter K, Portelance L, et al. A phase II study of intensity modulated radiation therapy (IMRT) to the pelvic for post-operative patients with endometrial carcinoma (RTOG 0418). RTOG Astro Presentations 2008,
12. Roeske JC, Lujan A, Rotmensch J, et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000, 48:1613-1621.
13. Mundt AJ, Lujan A, Rotmensch J, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2002, 51:261-266.
14. Portelance L, Chao KS, Grigsby PW, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001, 51:261-266.
15. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000, 355:1404-1411. 10.1016/S0140-6736(00)02139-5, 10791524.
16. Blake P, Swart AM, et al. ASTEC/EN.5 Study Group Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 2009, 373:137-146. 10.1016/S0140-6736(08)61767-5, 2646125, 19070891, ASTEC/EN.5 Study Group .